EP1223809A4 - Verfahren zur behandlung des haarausfalls durch verabreichung einer indolin-verbindung - Google Patents

Verfahren zur behandlung des haarausfalls durch verabreichung einer indolin-verbindung

Info

Publication number
EP1223809A4
EP1223809A4 EP00984592A EP00984592A EP1223809A4 EP 1223809 A4 EP1223809 A4 EP 1223809A4 EP 00984592 A EP00984592 A EP 00984592A EP 00984592 A EP00984592 A EP 00984592A EP 1223809 A4 EP1223809 A4 EP 1223809A4
Authority
EP
European Patent Office
Prior art keywords
administrating
hair loss
treating hair
indolin compound
indolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00984592A
Other languages
English (en)
French (fr)
Other versions
EP1223809A1 (de
Inventor
Karen Marie Lammers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UT Southwestern Medical Center
Original Assignee
UT Southwestern Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UT Southwestern Medical Center filed Critical UT Southwestern Medical Center
Publication of EP1223809A1 publication Critical patent/EP1223809A1/de
Publication of EP1223809A4 publication Critical patent/EP1223809A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
EP00984592A 1999-10-26 2000-10-20 Verfahren zur behandlung des haarausfalls durch verabreichung einer indolin-verbindung Withdrawn EP1223809A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16157799P 1999-10-26 1999-10-26
US161577P 1999-10-26
PCT/US2000/041383 WO2001030151A1 (en) 1999-10-26 2000-10-20 Methods of treating hair loss comprising administering indoline compound

Publications (2)

Publication Number Publication Date
EP1223809A1 EP1223809A1 (de) 2002-07-24
EP1223809A4 true EP1223809A4 (de) 2004-03-03

Family

ID=22581774

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00984592A Withdrawn EP1223809A4 (de) 1999-10-26 2000-10-20 Verfahren zur behandlung des haarausfalls durch verabreichung einer indolin-verbindung

Country Status (6)

Country Link
EP (1) EP1223809A4 (de)
JP (1) JP2003512396A (de)
AU (1) AU2119001A (de)
CA (1) CA2386889A1 (de)
MX (1) MXPA02004010A (de)
WO (1) WO2001030151A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
JP2006306791A (ja) * 2005-04-28 2006-11-09 Kanebo Cosmetics Inc 養毛剤
KR101857408B1 (ko) * 2018-02-28 2018-05-14 경북대학교 산학협력단 탈모 예방 또는 치료용 조성물
US20240024295A1 (en) * 2020-12-11 2024-01-25 Elise A. Olsen Compositions and methods for inhibiting hair growth

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
EP0648488A1 (de) * 1993-10-13 1995-04-19 L'oreal Verfahren zur Änderung das Haareswachstums und Zusammensetzungen dafür
WO1996031209A1 (en) * 1995-04-05 1996-10-10 Pfizer Inc. Pharmaceutical agents for the treatment of alzheimer's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO109195B1 (ro) * 1988-10-18 1994-12-30 Pfizer Derivati de 3-acil-2-oxindol-1-carboxamide
US5859042A (en) * 1995-09-27 1999-01-12 Ono Pharmaceutical Co., Ltd. Five membered heterocyclic compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
EP0648488A1 (de) * 1993-10-13 1995-04-19 L'oreal Verfahren zur Änderung das Haareswachstums und Zusammensetzungen dafür
WO1996031209A1 (en) * 1995-04-05 1996-10-10 Pfizer Inc. Pharmaceutical agents for the treatment of alzheimer's disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0130151A1 *

Also Published As

Publication number Publication date
JP2003512396A (ja) 2003-04-02
MXPA02004010A (es) 2002-10-23
CA2386889A1 (en) 2001-05-03
WO2001030151A1 (en) 2001-05-03
EP1223809A1 (de) 2002-07-24
AU2119001A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
DE60122532D1 (de) Verfahren zur behandlung von mehreren bohrlochintervallen
DE60226683D1 (de) Vorrichtungen zur Behandlung einer Tachykardie durch Herzreizung
DE69819786D1 (de) Biozidzusammensetzungen zur behandlung vom wasser
ATE426373T1 (de) Apparat zur behandlung von zahnen
DE60112813D1 (de) Verfahren zur behandlung einer verbrauchten glycolaufschlämmung
DE69806970D1 (de) Verfahren zur behandlung von hartgeweben
DE60102016D1 (de) Verfahren zur behandlung von beweggungsstörungen
DE60014831D1 (de) Verfahren zur behandlung der abwässer einer abgasenentschwefelungsanlage
DE60133206D1 (de) Verfahren zur bestimmung von parametern einer thermischen behandlung
DE122007000077I1 (de) Verfahren zur Herstellung von substituierten Octanoyl-Amiden
ATE308880T1 (de) Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung
EP1595852A4 (de) Verfahren zur behandlung von ammoniakalischen stickstoffenthaltendem wasser
EP1416953A4 (de) Verfahren zur behandlung von leberfibrose
ATA17552001A (de) Verfahren zur behandlung säurehältiger abwässer
DE60223688D1 (de) Verfahren zur behandlung von multiplem myelom
DE60114439D1 (de) Verfahren zur antimikrobiellen behandlung von fasermaterialien
DE60030748D1 (de) Verfahren zur herstellung von acrylnitril gekennzeichnet durch dem verwendeten katalysator
DE60216514D1 (de) Verfahren zur behandlung von dämpferkondensat
DE60217479D1 (de) Verfahren zur kontinuierlichen behandlung von wasser aus zahnärztlichen geräten
DE60235331D1 (de) Verfahren zur Herstellung von quartären Ammoniumsalzen
DE60138443D1 (de) Verfahren zur herstellung von siliziumeinkristallen
DE60024700D1 (de) Verfahren zur Herstellung einer Emulsion
ATE371453T1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
EP1223809A4 (de) Verfahren zur behandlung des haarausfalls durch verabreichung einer indolin-verbindung
DE60036999D1 (de) Verfahren zur kontinuierlichen Behandlung von verseiften Äthylen-Vinylacetat-Copolymeren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020415

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040121

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 01N 43/38 A

Ipc: 7A 61K 7/06 B

Ipc: 7A 61K 31/40 B

RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040403